Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
A clinical trial to look at how well RO6874281 works in combination with another drug called atezolizumab to slow, stop or reverse the course of solid tumours
Study to Evaluate the Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors
Cancer
Study results
LPS BP40234 Final Results August 2022 English
(PDF, 0.5 MB)
LPS BP40234 Final Results August 2022 English Belgium
(PDF, 0.6 MB)
LPS BP40234 Final Results August 2022 French Belgium
(PDF, 0.4 MB)
LPS BP40234 Final Results August 2022 Dutch Belgium
(PDF, 0.4 MB)
LPS BP40234 Final Results August 2022 Arabic Israel
(PDF, 0.8 MB)
LPS BP40234 Final Results August 2022 Hebrew Israel
(PDF, 0.9 MB)
LPS BP40234 Final Results August 2022 Russian Israel
(PDF, 0.7 MB)
LPS BP40234 Final Results August 2022 Polish Poland
(PDF, 0.6 MB)
LPS BP40234 Final Results August 2022 French France
(PDF, 0.3 MB)
LPS BP40234 Final Results August 2022 Russian Russia
(PDF, 0.9 MB)
LPS BP40234 Final Results August 2022 Spanish Spain
(PDF, 0.5 MB)
LPS BP40234 Final Results August 2022 Turkish Turkey
(PDF, 0.8 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com